Johnson & Johnson

JNJ Mega Cap

Healthcare · Drug Manufacturers - General

Updated: Apr 5, 2026, 00:03 UTC

$243.04

-0.44% today

52W: $141.50 – $251.71

52W Low: $141.50 Position: 92.1% 52W High: $251.71

🔗 Compare Brokers Best Broker for Beginners →

Key Metrics

P/E Ratio

22.03x

Price-to-Earnings

Forward P/E

19.33x

Forward Price/Earnings

P/S Ratio

6.22x

Price-to-Sales

EV/EBITDA

18.17x

Enterprise Value/EBITDA

Div. Yield

214%

Annual dividend yield

Market Cap

$585.7B

Market Capitalization

Revenue Growth

9.1%

YoY Revenue Growth

Profit Margin

28.46%

Net profit margin

ROE

35.03%

Return on Equity

Beta

0.33

Market sensitivity

Short Interest

1.08%

% of float sold short

Avg. Volume

8,869,391

Average daily volume

Valuation Analysis

Signal

Fair

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Buy

24 analysts

Avg. Price Target

$241.08

-0.81% upside

Target Range

$155.00 – $280.00

🚫 Not currently held by any of our 15 tracked Smart Money managers. View Smart Money Tracker →

About the Company

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospita

Sector: Healthcare Industry: Drug Manufacturers - General Country: United States Employees: 138,200 Exchange: NYQ